PTGS2 and esophageal cancer: -Decrease Bcl-2 expression, increase expression of caspase 3 and Bax in esophagus cancer-Induction of apoptosis and downregulation of PI3K, PKC, COX-2, and ROS. Increased expression of p53 and Bax in liver cancer.